GENEROSS Trademark

Trademark Overview

On Thursday, September 8, 2016, a trademark application was filed for GENEROSS with the United States Patent and Trademark Office. The USPTO has given the GENEROSS trademark a serial number of 79196319. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, December 1, 2023. This trademark is owned by SHELTAGEN MEDICAL LTD. The GENEROSS trademark is filed in the Pharmaceutical Products category with the following description:

Biological tissue grafts; implants comprising living tissue; Biological bone tissue intended for subsequent implantation; biological tissue cultures for medical purposes; implantable scaffolds comprising living tissue for maintaining tissue contour; implantable scaffolds comprising living tissue for enhancing therapy
geneross

General Information

Serial Number79196319
Word MarkGENEROSS
Filing DateThursday, September 8, 2016
Status709 - CANCELLED - SECTION 71
Status DateFriday, December 1, 2023
Registration Number5202418
Registration DateTuesday, May 16, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 28, 2017

Trademark Statements

Goods and ServicesBiological tissue grafts; implants comprising living tissue; Biological bone tissue intended for subsequent implantation; biological tissue cultures for medical purposes; implantable scaffolds comprising living tissue for maintaining tissue contour; implantable scaffolds comprising living tissue for enhancing therapy

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, December 1, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSHELTAGEN MEDICAL LTD
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressIL
Party NameSHELTAGEN MEDICAL LTD
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressIL
Party NameSHELTAGEN MEDICAL LTD
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressIL

Trademark Events

Event DateEvent Description
Thursday, December 15, 2016ASSIGNED TO EXAMINER
Thursday, November 17, 2016SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, November 21, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 25, 2016APPLICATION FILING RECEIPT MAILED
Friday, December 16, 2016NON-FINAL ACTION WRITTEN
Saturday, December 17, 2016NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, December 22, 2016REFUSAL PROCESSED BY MPU
Thursday, December 22, 2016NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, January 6, 2017REFUSAL PROCESSED BY IB
Tuesday, January 17, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, January 17, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 18, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 22, 2017NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, February 22, 2017NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, January 18, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, January 18, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, January 20, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 8, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 28, 2017PUBLISHED FOR OPPOSITION
Tuesday, February 28, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, August 16, 2017FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Monday, August 21, 2017FINAL DISPOSITION NOTICE SENT TO IB
Monday, May 16, 2022COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, December 1, 2023CANCELLED SECTION 71
Friday, March 10, 2017NOTIFICATION PROCESSED BY IB
Tuesday, May 16, 2017REGISTERED-PRINCIPAL REGISTER
Monday, August 21, 2017FINAL DISPOSITION PROCESSED
Friday, October 6, 2017FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, August 2, 2024TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Thursday, August 8, 2024INVALIDATION PROCESSED
Friday, August 9, 2024TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Saturday, August 31, 2024TOTAL INVALIDATION PROCESSED BY THE IB

Related Keywords

geneross tissue biological comprising living scaffolds implantable therapy maintaining purposes contour